NASDAQ:BIIB - Biogen Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $387.93
  • Forecasted Upside: 11.05 %
  • Number of Analysts: 32
  • Breakdown:
  • 0 Sell Ratings
  • 14 Hold Ratings
  • 18 Buy Ratings
  • 0 Strong Buy Ratings
▼ -22.56 (-6.07%)

This chart shows the closing price for BIIB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Biogen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BIIB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BIIB

Analyst Price Target is $387.93
▲ +11.05% Upside Potential
This price target is based on 32 analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is $387.93, with a high forecast of $500.00 and a low forecast of $244.00. The average price target represents a 11.05% upside from the last price of $349.34.

This chart shows the closing price for BIIB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 32 investment analysts is to buy stock in Biogen. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 17 buy ratings
  • 16 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 14 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 18 buy ratings
  • 13 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 18 buy ratings
  • 13 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 19 buy ratings
  • 14 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 18 buy ratings
  • 14 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 18 buy ratings
  • 12 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 18 buy ratings
  • 14 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 18 buy ratings
  • 14 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/18/2021Piper SandlerUpgradeNeutral ➝ Overweight$384.00 ➝ $450.00Low
6/15/2021Bank of AmericaReiterated RatingBuy$415.00Low
6/14/2021The Goldman Sachs GroupBoost Price TargetAverage ➝ Neutral$246.00 ➝ $436.00Low
6/11/2021Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$500.00Medium
6/10/2021UBS GroupUpgradeNeutral ➝ Buy$463.00Low
6/10/2021SVB LeerinkBoost Price TargetOutperform$380.00 ➝ $475.00Medium
6/8/2021William BlairUpgradeMarket Perform ➝ OutperformHigh
6/8/2021Royal Bank of CanadaBoost Price TargetSector Perform$259.00 ➝ $400.00High
6/8/2021Jefferies Financial GroupBoost Price TargetBuy$450.00 ➝ $500.00Medium
6/8/2021Morgan StanleyBoost Price TargetOverweight$343.00 ➝ $455.00Medium
6/8/2021BarclaysBoost Price TargetEqual Weight$265.00 ➝ $395.00Medium
6/8/2021HC WainwrightBoost Price TargetBuy$305.00 ➝ $452.00Medium
6/8/2021CitigroupUpgradeSell ➝ NeutralMedium
6/8/2021Atlantic SecuritiesUpgradeUnderweight ➝ Neutral$415.00Low
6/8/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellUpgradeSell ➝ Neutral$200.00 ➝ $440.00Low
6/7/2021Robert W. BairdUpgradeUnderperform ➝ Neutral$216.00 ➝ $382.00Medium
6/7/2021Raymond JamesUpgradeUnderperform ➝ Market PerformMedium
6/7/2021CowenUpgradeMarket Perform ➝ Outperform$225.00 ➝ $450.00High
6/7/2021Bank of AmericaUpgradeUnderperform ➝ Neutral$235.00 ➝ $400.00High
5/18/2021OppenheimerBoost Price TargetOutperform$300.00 ➝ $325.00Low
4/23/2021HC WainwrightReiterated RatingBuyLow
4/19/2021Morgan StanleyLower Price TargetOverweight$351.00 ➝ $343.00Low
4/12/2021WedbushBoost Price TargetNeutral$236.00 ➝ $245.00Medium
2/17/2021Cantor FitzgeraldLower Price TargetNeutral$278.00 ➝ $268.00Low
2/5/2021DZ BankDowngradeBuy ➝ Hold$264.00Low
2/4/2021Credit Suisse GroupLower Price TargetOutperform$388.00 ➝ $350.00Medium
2/4/2021SVB LeerinkLower Price TargetPositive ➝ Outperform$430.00 ➝ $380.00Medium
2/4/2021Morgan StanleyLower Price TargetOverweight$352.00 ➝ $351.00Medium
2/4/2021HC WainwrightBoost Price TargetBuy$289.00 ➝ $305.00Medium
2/3/2021Piper SandlerLower Price TargetNeutral$265.00 ➝ $250.00Low
1/29/2021Stifel NicolausUpgradeHold ➝ Buy$258.00 ➝ $358.00High
1/19/2021Morgan StanleyLower Price TargetOverweight$357.00 ➝ $352.00High
12/1/2020William BlairReiterated RatingMarket PerformLow
12/1/2020Royal Bank of CanadaBoost Price TargetReduce ➝ Sector Perform$249.00 ➝ $256.00Low
11/19/2020Royal Bank of CanadaBoost Price TargetSector Perform$244.00 ➝ $249.00Low
11/10/2020TruistDowngradeBuy$310.00 ➝ $443.00Low
11/10/2020DZ BankUpgradeHold ➝ Buy$265.00Low
11/9/2020Royal Bank of CanadaLower Price TargetSector Perform$263.00 ➝ $244.00High
11/9/2020OppenheimerLower Price TargetOutperform$370.00 ➝ $330.00Medium
11/9/2020MizuhoLower Price TargetNeutral$282.00 ➝ $244.00Medium
11/9/2020HC WainwrightLower Price TargetBuy$318.00 ➝ $289.00High
11/9/2020CowenDowngradeOutperform ➝ Market Perform$275.00 ➝ $215.00High
11/9/2020Bank of AmericaDowngradeNeutral ➝ Underperform$240.00High
11/9/2020Atlantic SecuritiesDowngradeNeutral ➝ Underweight$175.00High
11/5/2020Canaccord GenuityBoost Price TargetBuy$350.00 ➝ $393.00High
11/5/2020SVB LeerinkBoost Price TargetPositive ➝ Outperform$342.00 ➝ $402.00High
11/5/2020BMO Capital MarketsUpgradeMarket Perform$280.00 ➝ $343.00High
11/4/2020Bank of AmericaUpgradeUnderperform ➝ Neutral$230.00 ➝ $360.00High
11/4/2020Jefferies Financial GroupUpgradeHold ➝ Buy$450.00High
11/4/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$437.00 ➝ $390.00High
11/3/2020Cantor FitzgeraldLower Price Target$339.00 ➝ $278.00Low
10/28/2020UBS GroupInitiated CoverageNeutral$268.00High
10/27/2020MizuhoLower Price TargetNeutral$316.00 ➝ $282.00Low
10/22/2020HC WainwrightReiterated RatingBuyLow
10/22/2020OppenheimerLower Price TargetOutperform$360.00 ➝ $340.00Low
10/22/2020BarclaysLower Price TargetEqual Weight$275.00 ➝ $265.00Low
10/22/2020WedbushLower Price TargetNeutral$281.00 ➝ $244.00Low
10/22/2020Credit Suisse GroupLower Price TargetOutperform$359.00 ➝ $350.00Low
10/22/2020Morgan StanleyBoost Price TargetOverweight$355.00 ➝ $357.00Low
10/20/2020Piper SandlerLower Price TargetNeutral$270.00 ➝ $265.00Low
10/19/2020Royal Bank of CanadaLower Price TargetSector Perform$281.00 ➝ $268.00High
10/15/2020Bank of AmericaLower Price TargetUnderperform$255.00 ➝ $235.00Low
10/13/2020Morgan StanleyLower Price TargetOverweight$357.00 ➝ $355.00Low
9/29/2020Canaccord GenuityReiterated RatingBuy$396.00Low
9/18/2020Royal Bank of CanadaLower Price TargetSector Perform$284.00 ➝ $277.00High
9/13/2020JPMorgan Chase & Co.Reiterated RatingHoldHigh
8/19/2020SVB LeerinkLower Price TargetOutperform$350.00 ➝ $342.00Medium
8/7/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$270.00 ➝ $375.00Medium
8/7/2020OppenheimerBoost Price TargetOutperform$325.00 ➝ $360.00High
7/31/2020Raymond JamesReiterated RatingSellLow
7/29/2020JPMorgan Chase & Co.Reiterated RatingHold$279.00Low
7/27/2020Morgan StanleyUpgradeUnderweight ➝ Overweight$263.00 ➝ $357.00High
7/23/2020BMO Capital MarketsLower Price TargetMarket Perform$317.00 ➝ $280.00Low
7/22/2020MizuhoReiterated RatingHold$316.00Low
7/22/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$311.00 ➝ $324.00Low
7/22/2020Stifel NicolausLower Price TargetPositive ➝ Hold$294.00 ➝ $284.00Medium
7/16/2020OppenheimerReiterated RatingBuy$325.00Low
7/15/2020Morgan StanleyLower Price TargetUnderweight$301.00 ➝ $263.00Low
7/13/2020The Goldman Sachs GroupLower Price TargetNeutral$300.00 ➝ $257.00Medium
7/10/2020William BlairReiterated RatingHoldLow
7/8/2020SunTrust BanksReiterated RatingBuy$330.00Low
7/8/2020GuggenheimReiterated RatingBuy$390.00Low
7/6/2020Royal Bank of CanadaReiterated RatingHold$276.00Low
6/25/2020Credit Suisse GroupReiterated RatingHold$270.00Low
6/22/2020Royal Bank of CanadaLower Price TargetSector Perform$303.00 ➝ $273.00Low
6/22/2020BarclaysDowngradeOverweight ➝ Equal Weight$370.00 ➝ $280.00Low
6/19/2020JPMorgan Chase & Co.Reiterated RatingHoldMedium
6/19/2020William BlairReiterated RatingHoldHigh
6/19/2020Robert W. BairdLower Price TargetUnderperform$290.00 ➝ $228.00High
6/19/2020Credit Suisse GroupLower Price TargetNeutral$310.00 ➝ $270.00High
6/19/2020Piper SandlerLower Price TargetNeutral$307.00 ➝ $260.00High
6/18/2020MizuhoReiterated RatingHold$316.00High
6/9/2020Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$360.00 ➝ $297.00Medium
5/28/2020Morgan StanleyReiterated RatingSell$301.00Low
5/1/2020Cantor FitzgeraldReiterated RatingNeutral$361.00 ➝ $308.00Low
4/30/2020Royal Bank of CanadaReiterated RatingHold$310.00High
4/24/2020William BlairReiterated RatingHoldHigh
4/24/2020Canaccord GenuityLower Price TargetBuy$360.00 ➝ $350.00Medium
4/23/2020Morgan StanleyLower Price TargetUnderweight$302.00 ➝ $301.00Medium
4/23/2020SunTrust BanksLower Price TargetBuy$360.00 ➝ $330.00Medium
4/23/2020OppenheimerLower Price TargetOutperform$390.00 ➝ $365.00Low
4/23/2020Credit Suisse GroupLower Price TargetNeutral$344.00 ➝ $310.00Low
4/23/2020BarclaysLower Price TargetOverweight$389.00 ➝ $370.00Low
4/23/2020Royal Bank of CanadaLower Price TargetSector Perform$325.00 ➝ $310.00Low
4/23/2020CitigroupDowngradeNeutral ➝ Sell$365.00 ➝ $240.00Low
4/22/2020Raymond JamesDowngradeMarket Perform ➝ UnderperformMedium
4/22/2020Stifel NicolausLower Price TargetHold$296.00 ➝ $294.00High
4/22/2020WedbushLower Price TargetNeutral$306.00 ➝ $295.00High
4/22/2020MizuhoReiterated RatingHold$316.00High
4/8/2020SVB LeerinkReiterated RatingOutperformHigh
3/31/2020Wolfe ResearchInitiated CoverageMarket Perform$331.00Low
3/18/2020Royal Bank of CanadaReiterated RatingHold$335.00High
3/2/2020Canaccord GenuityReiterated RatingBuyHigh
2/27/2020BarclaysInitiated CoverageOverweight$389.00High
2/25/2020MizuhoBoost Price TargetNeutral$300.00 ➝ $316.00Medium
2/11/2020William BlairReiterated RatingMarket PerformLow
2/7/2020OppenheimerBoost Price Target$338.00 ➝ $390.00Low
2/7/2020Nomura SecuritiesBoost Price TargetBuy$320.00 ➝ $392.00Low
2/6/2020BMO Capital MarketsReiterated RatingMarket Perform$317.00Low
2/6/2020Morgan StanleyBoost Price TargetUnderweight$261.00 ➝ $302.00Low
2/6/2020SVB LeerinkBoost Price TargetOutperform ➝ Positive$350.00 ➝ $410.00Medium
2/6/2020Credit Suisse GroupBoost Price TargetNeutral$300.00 ➝ $330.00Medium
2/6/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$286.00 ➝ $311.00Low
2/6/2020JPMorgan Chase & Co.Reiterated RatingHoldMedium
2/6/2020Canaccord GenuityReiterated RatingBuy$360.00Medium
2/6/2020HC WainwrightReiterated RatingBuy$335.00Medium
2/6/2020Cantor FitzgeraldBoost Price TargetNeutral$315.00 ➝ $361.00Medium
2/5/2020MizuhoReiterated RatingHold$300.00Low
2/5/2020Robert W. BairdBoost Price TargetUnderperform ➝ Underperform$250.00 ➝ $290.00Low
2/3/2020SVB LeerinkBoost Price TargetOutperform$350.00 ➝ $410.00High
2/3/2020SunTrust BanksBoost Price TargetBuy$337.00 ➝ $360.00Medium
2/2/2020Credit Suisse GroupReiterated RatingOverweight ➝ Hold$330.00 ➝ $300.00Low
1/31/2020Morgan StanleyLower Price TargetUnderweight$270.00 ➝ $261.00Low
1/31/2020Cantor FitzgeraldBoost Price TargetPositive ➝ Neutral$300.00 ➝ $315.00High
1/30/2020WedbushReiterated RatingNeutralHigh
1/30/2020JPMorgan Chase & Co.Reiterated RatingHoldLow
1/27/2020Royal Bank of CanadaReiterated RatingHold$285.00Low
1/27/2020Canaccord GenuityUpgradeHold ➝ Buy$305.00 ➝ $360.00Medium
1/23/2020Credit Suisse GroupReiterated RatingHold$300.00Low
1/23/2020Robert W. BairdReiterated RatingSell$250.00Low
1/17/2020Morgan StanleyBoost Price TargetUnderweight$262.00 ➝ $270.00Low
1/2/2020CowenReiterated RatingBuy$325.00Low
12/13/2019Credit Suisse GroupUpgradeUnderperform ➝ Neutral$260.00 ➝ $300.00Medium
12/6/2019Raymond JamesReiterated RatingHoldLow
12/6/2019HC WainwrightReiterated RatingBuy$335.00Low
12/2/2019Robert W. BairdDowngradeNeutral ➝ Underperform$250.00Low
11/18/2019Royal Bank of CanadaReiterated RatingHold$267.00Medium
11/12/2019SunTrust BanksInitiated CoverageBuy$337.00Medium
11/1/2019Standpoint ResearchDowngradeBuy ➝ HoldLow
10/29/2019Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
10/25/2019William BlairReiterated RatingHoldLow
10/23/2019Bank of AmericaBoost Price TargetUnderperform$200.00 ➝ $235.00Low
10/23/2019Canaccord GenuityBoost Price TargetHold$285.00 ➝ $305.00Low
10/23/2019Credit Suisse GroupBoost Price TargetUnderperform$203.00 ➝ $260.00Low
10/23/2019JPMorgan Chase & Co.Boost Price TargetNeutral$244.00 ➝ $260.00Low
10/23/2019BMO Capital MarketsBoost Price TargetMarket Perform$250.00 ➝ $297.00Medium
10/23/2019CowenBoost Price TargetOutperform$275.00 ➝ $325.00High
10/23/2019Morgan StanleyBoost Price TargetUnderweight$212.00 ➝ $262.00High
10/23/2019SVB LeerinkUpgradeMarket Perform ➝ Outperform$256.00 ➝ $350.00High
10/23/2019HC WainwrightBoost Price TargetBuy$300.00 ➝ $335.00High
10/23/2019GuggenheimUpgradeNeutral ➝ Buy$256.00 ➝ $365.00Medium
10/22/2019Jefferies Financial GroupBoost Price TargetHold$255.00 ➝ $310.00High
10/22/2019Stifel NicolausBoost Price TargetPositive ➝ Hold$236.00 ➝ $296.00High
10/22/2019UBS GroupBoost Price TargetOutperform ➝ Positive$280.00 ➝ $334.00High
10/22/2019CowenReiterated RatingOutperform$275.00 ➝ $325.00High
10/22/2019MizuhoReiterated RatingHold$235.00High
10/16/2019Bank of AmericaInitiated CoverageUnderperform$200.00Low
10/15/2019OppenheimerSet Price TargetBuy$280.00Low
10/11/2019Morgan StanleyBoost Price TargetUnderweight$211.00 ➝ $212.00Medium
9/23/2019JPMorgan Chase & Co.Set Price TargetHold$244.00Low
9/6/2019Royal Bank of CanadaSet Price TargetHold$242.00High
7/30/2019CowenReiterated RatingBuy$275.00Low
7/26/2019Piper Jaffray CompaniesReiterated RatingHoldN/A
7/25/2019MizuhoReiterated RatingHoldLow
7/24/2019Canaccord GenuityBoost Price TargetHold$275.00 ➝ $285.00Medium
6/28/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$280.00 ➝ $250.00Medium
6/5/2019Standpoint ResearchUpgradeHold ➝ BuyLow
5/23/2019CitigroupReiterated RatingNeutral ➝ NeutralMedium
5/22/2019WedbushInitiated CoverageNeutral ➝ Neutral$231.00High
5/20/2019Credit Suisse GroupInitiated CoverageUnderperform$198.00Medium
5/9/2019BarclaysLower Price TargetEqual Weight$250.00 ➝ $245.00Medium
5/7/2019ArgusReiterated RatingHoldHigh
5/5/2019OppenheimerSet Price TargetBuy$290.00Medium
4/24/2019JPMorgan Chase & Co.Reiterated RatingHoldHigh
4/22/2019OppenheimerSet Price TargetBuy$290.00Low
4/22/2019MizuhoSet Price TargetHold$235.00Low
4/10/2019Raymond JamesInitiated CoverageMarket PerformLow
3/27/2019Cantor FitzgeraldReiterated RatingHold$250.00Low
3/25/2019Royal Bank of CanadaLower Price TargetSector Perform$236.00Low
3/25/2019HC WainwrightReiterated RatingBuy ➝ Buy$363.00 ➝ $300.00Low
3/22/2019GuggenheimSet Price TargetHold$236.00Medium
3/22/2019BarclaysReiterated RatingHold$250.00High
3/22/2019Nomura SecuritiesLower Price TargetBuy ➝ Buy$420.00 ➝ $320.00High
3/22/2019BMO Capital MarketsLower Price TargetMarket Perform$322.00 ➝ $250.00High
3/22/2019UBS GroupDowngradeBuy ➝ Neutral$395.00 ➝ $242.00High
3/22/2019Morgan StanleyDowngradeOverweight ➝ Underweight$401.00 ➝ $210.00High
3/21/2019CitigroupDowngradeBuy ➝ Neutral$470.00 ➝ $230.00High
3/21/2019Stifel NicolausReiterated RatingHold$346.00 ➝ $233.00High
3/21/2019Canaccord GenuityDowngradeBuy ➝ Hold$396.00 ➝ $275.00High
3/21/2019Cantor FitzgeraldReiterated RatingOverweight ➝ Neutral$400.00High
3/21/2019The Goldman Sachs GroupDowngradeBuy ➝ NeutralHigh
3/21/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$244.00High
3/21/2019MizuhoDowngradeBuy ➝ Neutral$416.00 ➝ $235.00High
3/21/2019Bank of AmericaDowngradeBuy ➝ NeutralHigh
3/21/2019BTIG ResearchDowngradeBuy ➝ NeutralHigh
3/21/2019CowenLower Price TargetOutperform$400.00 ➝ $275.00High
3/21/2019GuggenheimReiterated RatingNeutral ➝ Neutral$325.00High
3/21/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformHigh
3/21/2019Atlantic SecuritiesDowngradeOverweight ➝ NeutralHigh
3/21/2019William BlairDowngradeOutperform ➝ Market PerformHigh
3/21/2019Piper Jaffray CompaniesLower Price TargetMarket Perform ➝ Overweight$402.00 ➝ $280.00High
2/22/2019BMO Capital MarketsInitiated CoverageNeutral ➝ Market Perform$322.00Low
2/22/2019GuggenheimDowngradeBuy ➝ Neutral$410.00 ➝ $325.00Low
2/21/2019Stifel NicolausDowngradeBuy ➝ Hold$397.00 ➝ $346.00High
2/19/2019HC WainwrightReiterated RatingBuy$363.00Low
2/14/2019OppenheimerLower Price TargetOutperform$380.00 ➝ $375.00High
2/14/2019Royal Bank of CanadaReiterated RatingMarket PerformLow
2/12/2019Royal Bank of CanadaLower Price TargetSector Perform ➝ Fair Value$337.00 ➝ $318.00Low
1/30/2019CitigroupBoost Price TargetOutperform$372.00 ➝ $380.00High
1/30/2019SVB LeerinkBoost Price TargetMarket Perform$328.00 ➝ $341.00High
1/29/2019MizuhoSet Price TargetBuy$427.00High
1/29/2019Stifel NicolausBoost Price TargetBuy$392.00 ➝ $397.00Low
1/25/2019OppenheimerSet Price TargetBuy$372.00Medium
1/10/2019JPMorgan Chase & Co.Reiterated RatingBuyLow
12/26/2018BTIG ResearchInitiated CoverageBuyHigh
12/20/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$362.00High
12/19/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$394.00 ➝ $401.00Low
12/18/2018OppenheimerLower Price TargetOutperform$380.00 ➝ $372.00High
12/12/2018OppenheimerSet Price TargetBuy$380.00Low
12/12/2018Cantor FitzgeraldReiterated RatingBuy$400.00Low
11/26/2018Royal Bank of CanadaLower Price TargetSector Perform$338.00Low
10/28/2018OppenheimerSet Price TargetBuy$400.00 ➝ $380.00Low
10/24/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Buy$445.00 ➝ $436.00High
10/24/2018SVB LeerinkSet Price TargetHold$328.00 ➝ $340.00High
10/23/2018Raymond JamesSet Price TargetBuy$400.00Medium
10/23/2018MizuhoSet Price TargetBuy$427.00Low
10/19/2018Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$373.00 ➝ $341.00High
10/19/2018OppenheimerSet Price TargetBuy$400.00High
10/8/2018CitigroupLower Price TargetBuy ➝ Buy$483.00 ➝ $470.00Low
10/3/2018Raymond JamesReiterated RatingBuyLow
10/1/2018Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00Low
9/16/2018OppenheimerSet Price TargetBuy$400.00Medium
8/7/2018Stifel NicolausInitiated CoverageBuy$394.00High
7/31/2018MizuhoReiterated RatingBuy$427.00Low
7/29/2018OppenheimerSet Price TargetBuy$400.00Medium
7/26/2018CitigroupBoost Price TargetBuy ➝ Positive$483.00Medium
7/26/2018UBS GroupBoost Price TargetBuy ➝ Buy$354.00 ➝ $395.00Medium
7/25/2018Cantor FitzgeraldSet Price TargetHold$293.00Low
7/25/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$295.00 ➝ $320.00High
7/25/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$323.00 ➝ $348.00High
7/25/2018SunTrust BanksBoost Price TargetBuy$321.00 ➝ $392.00High
7/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$366.00 ➝ $392.00High
7/24/2018GuggenheimReiterated RatingBuy$410.00High
7/24/2018CowenReiterated RatingBuy$408.00High
7/24/2018MizuhoReiterated RatingBuy$423.00High
7/24/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Hold$400.00 ➝ $445.00High
7/23/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$335.00 ➝ $396.00Low
7/13/2018Morgan StanleyLower Price TargetOverweight$369.00 ➝ $366.00Low
7/11/2018Piper Jaffray CompaniesBoost Price TargetOverweight$365.00Low
7/10/2018Royal Bank of CanadaBoost Price TargetMarket Perform$349.00Medium
7/10/2018Robert W. BairdDowngradeOutperform ➝ Neutral$323.00Medium
7/9/2018UBS GroupDowngradeBuy ➝ HoldMedium
7/9/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Hold$400.00Medium
7/9/2018HC WainwrightReiterated RatingBuyMedium
7/8/2018OppenheimerSet Price TargetBuy$375.00 ➝ $400.00Medium
7/6/2018Nomura SecuritiesReiterated RatingBuy$420.00High
7/6/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
7/6/2018Canaccord GenuitySet Price TargetBuy$335.00High
7/6/2018CitigroupUpgradeNeutral ➝ Buy$371.00High
7/6/2018MizuhoSet Price TargetBuy$423.00High
6/29/2018MizuhoSet Price TargetBuy$423.00Medium
6/6/2018Canaccord GenuitySet Price TargetBuy$335.00Medium
6/5/2018MizuhoSet Price TargetBuy$423.00Medium
5/31/2018Canaccord GenuityUpgradeHold ➝ Buy$350.00 ➝ $335.00Low
5/3/2018MizuhoSet Price TargetBuy$423.00Low
5/2/2018CitigroupLower Price TargetNeutral ➝ Neutral$360.00 ➝ $290.00Low
4/26/2018Cantor FitzgeraldReiterated RatingNeutralMedium
4/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$365.00 ➝ $369.00Low
4/25/2018CitigroupReiterated RatingOutperform$400.00 ➝ $375.00High
4/25/2018SVB LeerinkSet Price TargetMarket Perform ➝ Hold$365.00 ➝ $325.00High
4/25/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$388.00 ➝ $262.15High
4/25/2018Robert W. BairdUpgradeNeutral ➝ OutperformHigh
4/24/2018OppenheimerSet Price TargetBuy$375.00High
4/24/2018Stifel NicolausSet Price TargetBuy$425.00High
4/24/2018GuggenheimSet Price TargetBuy$385.00High
4/24/2018Credit Suisse GroupSet Price TargetBuy$384.00High
4/24/2018SunTrust BanksSet Price TargetBuy$321.00High
4/24/2018Piper Jaffray CompaniesLower Price TargetOverweightHigh
4/24/2018CowenReiterated RatingBuy$408.00High
4/24/2018MizuhoSet Price TargetBuy$433.00High
4/24/2018Jefferies Financial GroupReiterated RatingHold$375.00 ➝ $300.00High
4/17/2018Credit Suisse GroupSet Price TargetBuy$384.00Medium
4/11/2018MizuhoSet Price TargetBuy$433.00Low
4/10/2018Sanford C. BernsteinSet Price TargetBuy$318.00Medium
4/9/2018Canaccord GenuitySet Price TargetHold$350.00Medium
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$395.00 ➝ $295.00High
3/12/2018MizuhoSet Price TargetBuy$433.00Medium
3/12/2018Credit Suisse GroupReiterated RatingBuy$384.00Medium
3/2/2018GuggenheimSet Price TargetBuy$400.00Low
3/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$403.00 ➝ $393.00Low
2/16/2018ArgusDowngradeBuy ➝ HoldMedium
2/15/2018Canaccord GenuitySet Price TargetHold$350.00Low
2/15/2018William BlairReiterated RatingBuyLow
2/8/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
2/7/2018Credit Suisse GroupUpgradeBuy$384.00High
2/7/2018Canaccord GenuityReiterated RatingHold$350.00High
2/4/2018MizuhoReiterated RatingBuy ➝ Buy$400.00 ➝ $433.00High
1/31/2018UBS GroupUpgradeNeutral ➝ Buy$352.59 ➝ $410.00Low
1/26/2018OppenheimerBoost Price TargetOutperform ➝ Buy$380.00 ➝ $400.00Low
1/26/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy$373.00Low
1/26/2018Jefferies Financial GroupReiterated RatingHoldMedium
1/26/2018Royal Bank of CanadaBoost Price TargetSector Perform$347.00High
1/26/2018SunTrust BanksBoost Price TargetBuy$392.00High
1/26/2018HC WainwrightReiterated RatingBuy ➝ Buy$340.00 ➝ $363.00High
1/26/2018CowenReiterated RatingBuy$408.00High
1/25/2018BMO Capital MarketsReiterated RatingBuyHigh
1/25/2018Robert W. BairdReiterated RatingNeutral ➝ HoldHigh
1/25/2018JPMorgan Chase & Co.Set Price TargetBuy$378.00Medium
1/25/2018The Goldman Sachs GroupSet Price TargetBuy$390.00Medium
1/24/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$340.00 ➝ $350.00Medium
1/21/2018BarclaysReiterated RatingBuy$395.00Medium
1/18/2018MizuhoSet Price TargetBuy$400.00Low
1/16/2018Canaccord GenuitySet Price TargetHold ➝ Hold$340.00 ➝ $350.00High
1/16/2018CitigroupReiterated RatingOutperform$350.00 ➝ $380.00Medium
1/15/2018OppenheimerSet Price TargetBuy$380.00Medium
1/5/2018Canaccord GenuitySet Price TargetHold$340.00High
1/5/2018MizuhoSet Price TargetBuy$400.00High
1/2/2018Piper Jaffray CompaniesReiterated RatingBuyHigh
12/30/2017Nomura SecuritiesBoost Price TargetBuy$355.00 ➝ $420.00N/A
12/22/2017Nomura SecuritiesBoost Price TargetBuy ➝ Buy$355.00 ➝ $420.00Low
12/21/2017MizuhoSet Price TargetBuy$400.00Low
12/20/2017Canaccord GenuitySet Price TargetHold$340.00Low
12/20/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$321.00 ➝ $385.00Low
12/18/2017Piper Jaffray CompaniesReiterated RatingBuy$390.00Low
12/5/2017Royal Bank of CanadaReiterated RatingHold$321.00Low
12/4/2017OppenheimerSet Price TargetBuy$350.00Low
11/28/2017OppenheimerSet Price TargetBuy$350.00Low
11/28/2017Sanford C. BernsteinSet Price TargetBuy$310.00 ➝ $318.00Medium
11/27/2017CowenReiterated RatingBuy$338.00Low
11/27/2017BMO Capital MarketsReiterated RatingBuy$385.00Low
11/27/2017JPMorgan Chase & Co.Set Price TargetBuy$378.00Medium
11/27/2017MizuhoSet Price TargetBuy$400.00Medium
11/22/2017OppenheimerReiterated RatingBuy$350.00N/A
11/13/2017MizuhoSet Price TargetBuy$400.00N/A
11/9/2017OppenheimerInitiated CoverageOutperform$350.00 ➝ $350.00N/A
11/6/2017BMO Capital MarketsBoost Price TargetOutperform$381.00 ➝ $386.00N/A
10/27/2017Canaccord GenuityInitiated CoverageHold ➝ Hold$340.00N/A
10/25/2017HC WainwrightReiterated RatingBuy$340.00N/A
10/25/2017Royal Bank of CanadaLower Price TargetSector Perform ➝ Sector Perform$315.00 ➝ $313.00N/A
10/25/2017UBS GroupBoost Price TargetNeutral$285.00 ➝ $318.00N/A
10/25/2017BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$377.00N/A
10/24/2017SunTrust BanksReiterated RatingBuy$354.00N/A
10/24/2017Cantor FitzgeraldReiterated RatingHold$279.00N/A
10/23/2017GuggenheimInitiated CoverageBuy$402.00N/A
10/23/2017Piper Jaffray CompaniesReiterated RatingOverweight ➝ Overweight$390.00N/A
10/23/2017CitigroupDowngradeBuy ➝ NeutralN/A
10/18/2017Bank of AmericaBoost Price TargetBuy$358.00 ➝ $365.00N/A
10/17/2017Morgan StanleyReiterated RatingBuyN/A
10/17/2017MizuhoUpgradeNeutral ➝ Buy$319.00 ➝ $400.00N/A
10/17/2017Stifel NicolausUpgradeHold ➝ Buy$300.00 ➝ $415.00N/A
10/12/2017Stifel NicolausReiterated RatingHold$300.00N/A
10/5/2017Royal Bank of CanadaReiterated RatingHold$315.00N/A
10/5/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$311.00 ➝ $375.00N/A
10/2/2017MizuhoReiterated RatingNeutral$319.00Low
9/21/2017Raymond JamesDowngradeStrong-Buy ➝ Market Perform$244.28 ➝ $319.00Low
9/20/2017SunTrust BanksInitiated CoverageBuy ➝ Buy$360.00Low
9/14/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$319.00Medium
9/13/2017BMO Capital MarketsBoost Price TargetMarket Perform$328.00 ➝ $377.00Low
9/13/2017MizuhoReiterated RatingNeutral$274.00 ➝ $319.00Medium
8/25/2017Robert W. BairdReiterated RatingHold$290.00Low
8/16/2017The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$338.00Low
7/27/2017CowenReiterated RatingBuyMedium
7/26/2017BMO Capital MarketsReiterated RatingMarket Perform$317.00 ➝ $328.00Medium
7/26/2017UBS GroupReiterated RatingNeutral$270.00 ➝ $285.00Low
7/26/2017Morgan StanleyReiterated RatingEqual Weight$301.00 ➝ $311.00Low
7/26/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$315.00 ➝ $319.00Low
7/26/2017SVB LeerinkReiterated RatingMarket Perform$304.00 ➝ $338.00High
7/26/2017The Goldman Sachs GroupUpgradeNeutral ➝ Buy$228.00 ➝ $338.00High
7/18/2017BMO Capital MarketsReiterated RatingHold$318.00Low
7/14/2017Credit Suisse GroupSet Price TargetHold$300.00Low
7/11/2017Jefferies Financial GroupReiterated RatingHold ➝ Hold$310.00Low
7/10/2017Morgan StanleyReiterated RatingEqual WeightLow
7/3/2017CowenReiterated RatingOutperform$271.00Medium
6/26/2017William BlairReiterated RatingOutperformHigh
6/23/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$315.00Low
6/22/2017SVB LeerinkReiterated RatingMarket PerformLow
6/19/2017UBS GroupUpgradeSell ➝ Neutral$262.00 ➝ $270.00N/A
6/14/2017Morgan StanleyReiterated RatingEqual Weight$307.00Low
6/2/2017BMO Capital MarketsReiterated RatingHold$318.00Medium
5/31/2017MizuhoLower Price TargetNeutral$290.00 ➝ $274.00Low
5/25/2017Sanford C. BernsteinReiterated RatingOutperformLow
5/25/2017Cantor FitzgeraldReiterated RatingHold$277.00Low
5/15/2017Piper Jaffray CompaniesSet Price TargetBuy$332.00 ➝ $442.00Low
4/27/2017MizuhoReiterated RatingHoldMedium
4/26/2017Stifel NicolausBoost Price TargetHold$265.00 ➝ $280.00Medium
4/25/2017CowenReiterated RatingBuy$338.00High
4/25/2017Cantor FitzgeraldSet Price TargetHold$278.00Low
4/25/2017Sanford C. BernsteinReiterated RatingOutperform$310.00Medium
4/23/2017BarclaysReiterated RatingOverweight$380.00 ➝ $360.00Medium
4/18/2017MizuhoReiterated RatingHold$290.00Low
4/18/2017Robert W. BairdReiterated RatingNeutral$290.00Low
4/10/2017SVB LeerinkLower Price TargetMarket Perform$300.00 ➝ $290.00Low
4/4/2017Jefferies Financial GroupSet Price TargetHold$289.00Low
4/4/2017CitigroupBoost Price TargetBuy$305.00 ➝ $315.00Low
4/3/2017SVB LeerinkSet Price TargetHold$300.00Low
4/3/2017Credit Suisse GroupReiterated RatingNeutral$296.00Low
4/3/2017MizuhoReiterated RatingNeutral$290.00Low
3/29/2017Cantor FitzgeraldReiterated RatingNeutralHigh
3/29/2017Robert W. BairdReiterated RatingNeutral$290.00Low
3/22/2017MizuhoReiterated RatingNeutral$290.00Low
3/16/2017SVB LeerinkDowngradeOutperform ➝ Market Perform$300.00High
3/16/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$369.00 ➝ $305.00High
3/11/2017UBS GroupReiterated RatingSell$260.00N/A
3/7/2017Robert W. BairdReiterated RatingNeutral$290.00N/A
3/1/2017Nomura InstinetInitiated CoverageBuy ➝ Buy$223.03 ➝ $345.00N/A
3/1/2017Nomura SecuritiesInitiated CoverageNeutralN/A
2/24/2017Sanford C. BernsteinReiterated RatingOutperform$310.00N/A
2/11/2017Credit Suisse GroupSet Price TargetHold$296.00N/A
2/7/2017CitigroupUpgradeNeutral ➝ Buy$305.00N/A
2/7/2017Robert W. BairdReiterated RatingHoldN/A
2/6/2017MizuhoReiterated RatingSellN/A
2/4/2017Credit Suisse GroupSet Price TargetHold$296.00N/A
2/2/2017Royal Bank of CanadaReiterated RatingBuyN/A
1/30/2017HC WainwrightReiterated RatingBuy$360.00N/A
1/27/2017Morgan StanleyBoost Price TargetOverweight$353.00 ➝ $369.00N/A
1/26/2017Cantor FitzgeraldSet Price TargetHold$293.00N/A
1/24/2017Credit Suisse GroupSet Price TargetHold$314.00N/A
1/24/2017BMO Capital MarketsReiterated RatingMarket Perform$336.00N/A
1/24/2017Jefferies Financial GroupReiterated RatingHold$313.00N/A
1/18/2017SVB LeerinkSet Price TargetBuy$360.00N/A
1/18/2017Cantor FitzgeraldReiterated RatingHold$293.00N/A
1/18/2017Jefferies Financial GroupReiterated RatingHoldN/A
1/18/2017JPMorgan Chase & Co.Reiterated RatingBuyN/A
1/18/2017MizuhoReiterated RatingHold$290.00N/A
1/17/2017Piper Jaffray CompaniesSet Price TargetBuy$335.00N/A
1/17/2017Robert W. BairdReiterated RatingPositive$309.00N/A
1/17/2017Stifel NicolausSet Price TargetHold$298.00N/A
1/8/2017BMO Capital MarketsSet Price TargetHold$336.00N/A
1/8/2017Jefferies Financial GroupReiterated RatingHold$312.00N/A
1/6/2017Cantor FitzgeraldReiterated RatingHoldN/A
12/30/2016CowenReiterated RatingBuy$368.00N/A
12/30/2016Credit Suisse GroupReiterated RatingNeutral$312.00N/A
12/29/2016Raymond JamesBoost Price TargetStrong-Buy$375.00 ➝ $386.00N/A
12/28/2016JPMorgan Chase & Co.Reiterated RatingOverweight$384.00N/A
12/27/2016SVB LeerinkReiterated RatingOutperform$355.00 ➝ $368.00N/A
12/23/2016Robert W. BairdReiterated RatingNeutral$309.00N/A
12/22/2016BMO Capital MarketsReiterated RatingMarket Perform$328.00N/A
12/21/2016Jefferies Financial GroupReiterated RatingHold$310.00N/A
12/21/2016CowenReiterated RatingOutperform$368.00N/A
12/20/2016Credit Suisse GroupReiterated RatingHold$312.00N/A
12/15/2016Cantor FitzgeraldInitiated CoverageNeutral$293.00N/A
12/12/2016HC WainwrightSet Price TargetBuy$360.00N/A
12/10/2016MizuhoSet Price TargetHold$290.00N/A
12/9/2016Jefferies Financial GroupSet Price TargetHold$310.00N/A
12/9/2016Piper Jaffray CompaniesSet Price TargetBuy$335.00N/A
12/9/2016Robert W. BairdReiterated RatingNeutral$284.00 ➝ $309.00N/A
12/9/2016Stifel NicolausBoost Price TargetHold$291.00 ➝ $298.00N/A
12/4/2016BMO Capital MarketsReiterated RatingMarket Perform$294.00 ➝ $331.00N/A
12/1/2016MizuhoReiterated RatingHold$290.00N/A
11/26/2016Robert W. BairdReiterated RatingNeutral$284.00N/A
11/26/2016BMO Capital MarketsReiterated RatingMarket Perform$294.00N/A
11/25/2016SVB LeerinkLower Price TargetOutperform$365.00 ➝ $355.00N/A
11/24/2016Credit Suisse GroupSet Price TargetHold$322.00N/A
11/24/2016Piper Jaffray CompaniesSet Price TargetBuy$335.00N/A
11/7/2016MizuhoInitiated CoverageNeutral$290.00N/A
11/7/2016SVB LeerinkUpgradeMarket Perform ➝ OutperformN/A
11/7/2016Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$335.00N/A
10/27/2016HC WainwrightReiterated RatingBuyN/A
10/27/2016SVB LeerinkReiterated RatingMarket Perform$367.00 ➝ $361.00N/A
10/26/2016CowenReiterated RatingBuy$368.00N/A
10/12/2016SVB LeerinkSet Price TargetHold$367.00N/A
10/12/2016HC WainwrightReiterated RatingBuy$360.00N/A
10/7/2016JPMorgan Chase & Co.Reiterated RatingOverweight$386.00N/A
10/5/2016Jefferies Financial GroupLower Price TargetHold$323.00 ➝ $316.00N/A
10/4/2016BMO Capital MarketsReiterated RatingMarket Perform$304.00N/A
10/4/2016Royal Bank of CanadaReiterated RatingBuy$375.00N/A
9/22/2016Piper Jaffray CompaniesSet Price TargetHold$333.00N/A
9/22/2016Bank of AmericaReiterated RatingBuy$374.00N/A
9/20/2016HC WainwrightReiterated RatingBuy$360.00N/A
9/18/2016Credit Suisse GroupSet Price TargetHold$322.00N/A
9/16/2016JPMorgan Chase & Co.Reiterated RatingBuy$386.00N/A
9/16/2016Stifel NicolausReiterated RatingHoldN/A
9/8/2016HC WainwrightReiterated RatingBuy$360.00N/A
9/6/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$323.00N/A
9/4/2016Jefferies Financial GroupReiterated RatingBuy ➝ Buy$319.00N/A
8/23/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/17/2016Morgan StanleyLower Price TargetOverweight$385.00 ➝ $368.00N/A
8/16/2016Piper Jaffray CompaniesReiterated RatingNeutral$293.00 ➝ $333.00N/A
8/10/2016Robert W. BairdReiterated RatingNeutral$284.00N/A
8/9/2016SVB LeerinkReiterated RatingHold$367.00N/A
8/4/2016Jefferies Financial GroupReiterated RatingBuy$319.00N/A
8/3/2016Piper Jaffray CompaniesReiterated RatingNeutralN/A
8/3/2016Morgan StanleyReiterated RatingBuy$385.00N/A
8/3/2016Credit Suisse GroupReiterated RatingHold$322.00N/A
8/2/2016Standpoint ResearchDowngradeBuy ➝ HoldN/A
8/2/2016Raymond JamesBoost Price TargetStrong-Buy$360.00 ➝ $375.00N/A
8/1/2016Robert W. BairdReiterated RatingPositive$268.00 ➝ $284.00N/A
8/1/2016SVB LeerinkBoost Price TargetMarket Perform$360.00 ➝ $367.00N/A
8/1/2016BMO Capital MarketsBoost Price TargetMarket Perform$286.00 ➝ $304.00N/A
7/26/2016Jefferies Financial GroupReiterated RatingBuy$319.00N/A
7/25/2016Robert W. BairdReiterated RatingNeutral$268.00N/A
7/24/2016HC WainwrightReiterated RatingBuy$360.00N/A
7/24/2016BMO Capital MarketsReiterated RatingMarket Perform$287.00N/A
7/24/2016SVB LeerinkReiterated RatingMarket Perform$319.00N/A
7/22/2016Credit Suisse GroupReiterated RatingHold$312.00N/A
7/21/2016Piper Jaffray CompaniesSet Price TargetHold$293.00N/A
7/21/2016Morgan StanleyBoost Price TargetOverweight$383.00 ➝ $385.00N/A
7/13/2016Jefferies Financial GroupReiterated RatingBuy$317.00N/A
6/30/2016Morgan StanleyReiterated RatingBuyN/A
6/30/2016Jefferies Financial GroupReiterated RatingBuyN/A
6/30/2016SVB LeerinkReiterated RatingHoldN/A
6/30/2016Bank of AmericaReiterated RatingBuyN/A
6/29/2016Sanford C. BernsteinInitiated CoverageOutperform$282.00N/A
(Data available from 6/24/2016 forward)
Biogen logo
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB111 and BIIB112 to treat ophthalmology related diseases; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and TMS-007 to treat acute neurology; BIIB074 and BIIB095 for neuropathic pain; and SB11 and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Ginkgo Bioworks; and Capsigen Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $349.34
Low: $339.70
High: $363.52

50 Day Range

MA: $303.97
Low: $259.00
High: $414.71

52 Week Range

Now: $349.34
Low: $223.25
High: $468.55


221,048 shs

Average Volume

1,579,510 shs

Market Capitalization

$52.59 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Biogen?

The following Wall Street analysts have issued reports on Biogen in the last twelve months: Atlantic Securities, Bank of America Co., Barclays PLC, BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cowen Inc, Credit Suisse Group AG, DZ Bank AG, Guggenheim, HC Wainwright, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, SunTrust Banks, Inc., SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, UBS Group AG, Wedbush, Wells Fargo & Company, and William Blair.
View the latest analyst ratings for BIIB.

What is the current price target for Biogen?

29 Wall Street analysts have set twelve-month price targets for Biogen in the last year. Their average twelve-month price target is $387.93, suggesting a possible upside of 4.3%. Jefferies Financial Group Inc. has the highest price target set, predicting BIIB will reach $500.00 in the next twelve months. Mizuho has the lowest price target set, forecasting a price of $244.00 for Biogen in the next year.
View the latest price targets for BIIB.

What is the current consensus analyst rating for Biogen?

Biogen currently has 14 hold ratings and 18 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BIIB will outperform the market and that investors should add to their positions of Biogen.
View the latest ratings for BIIB.

What other companies compete with Biogen?

How do I contact Biogen's investor relations team?

Biogen's physical mailing address is 225 BINNEY STREET, CAMBRIDGE MA, 02142. The biotechnology company's listed phone number is 617-679-2000 and its investor relations email address is [email protected] The official website for Biogen is